1-4 of 4
Carlos M. Martins, MD
Close
Sort by
Journal Articles

Increased Naive, Stem Cell Memory and Terminally Differentiated CD8+ T Cells in Chronic Graft Versus Host Disease

Maria V Soares, PhD, Rita I Azevedo, PhD, Inês A Ferreira, MSc, Bucar Ventura Sara, MSc, Dario Ligeiro, PhD, Ana C Ribeiro, MSc, Paulo N.G. Pereira, Ana C Alho, MD, Eduardo L Espada, MD, Clara Juncal, MD, Nádia Camacho, BSc, Carlos M Martins, MD, José A Carmo, MD, Fernanda Lourenço, MD, Raul Moreno, MD, Carlos Vaz, MD, António Campos, MD, Fernando Campilho, MD, Rosa Ferreira, MD, Jerome Ritz, MD, Joao F Lacerda, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3260.
https://doi.org/10.1182/blood.V130.Suppl_1.3260.3260
Published: 2017
Journal Articles

TREG and Tcon Dynamics after Allo-HSCT: Cgvhd Is Associated to Decreased NaïVe and Stem Cell Memory Subsets with a Concomitant Increase in Terminally Differentiated T Cell Subsets

Maria V.D. Soares, PhD, Rita I Azevedo, PhD, Ines A Ferreira, MSc, Sara Ventura Bucar, MSc, Ana Cristina Alho, MD, Eduardo L Espada, MD, Juncal Clara, MD, Nadia Camacho, BSc, Carlos M. Martins, MD, José A Carmo, MD, Fernanda Lourenço, MD, Raul Moreno, MD, Carlos Vaz, MD, Antonio M. Campos, MD, Fernando Campilho, MD, Rosa Ferreira, MD, Jerome Ritz, MD, Joao F Lacerda, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2229.
https://doi.org/10.1182/blood.V128.22.2229.2229
Published: 2016
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Graça Esteves, MD, Manuel L Neves, Helena Martins, Carlos M. Martins, MD, Maria Joao Costa, MD, Sara Valle, MD, Conceição Lopes, MD, João Raposo, MD, Lurdes Guerra, MD, Blanca Polo, MD, Ana Alho, Carolina Viveiros, MD, Susana Mendes, Rita Ferreira, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 1873.
https://doi.org/10.1182/blood.V122.21.1873.1873
Published: 2013
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

Graça V Esteves, MD, Manuel L Neves, Helena F Martins, Maria Joao Costa, MD, Sara Valle, MD, João Raposo, MD, Carlos M. Martins, MD, Lurdes Guerra, MD, Conceição Lopes, MD, Susana Mendes, Ana Alho, Rita Ferreira, Carolina Viveiros, MD, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Blanca Polo, MD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 3150.
https://doi.org/10.1182/blood.V122.21.3150.3150
Published: 2013